The Efficacy and Potential Mechanisms of Metformin in the Treatment of COVID-19 in the Diabetics: A Systematic Review

Diabetes mellitus (DM) is one of the most common comorbidities among patients with coronavirus disease 2019 (COVID-19) which may exacerbate complications of this new viral infection. Metformin is an anti-hyperglycemic agent with host-directed immune-modulatory effects, which relieve exaggerated infl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontiers in endocrinology (Lausanne) Jg. 12; S. 645194
Hauptverfasser:	Zangiabadian, Moein, Nejadghaderi, Seyed Aria, Zahmatkesh, Mohammad Mahdi, Hajikhani, Bahareh, Mirsaeidi, Mehdi, Nasiri, Mohammad Javad
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	Switzerland Frontiers Media S.A 19.03.2021
Schlagworte:	2019-nCoV COVID-19 COVID-19 - complications COVID-19 - drug therapy Diabetes Complications - drug therapy diabetes mellitus Diabetes Mellitus - drug therapy Endocrinology Humans Hypoglycemic Agents - therapeutic use metformin Metformin - therapeutic use SARS-CoV-2 systematic review COVID-19 metformin SARS-CoV-2 diabetes mellitus 2019-nCoV systematic review
ISSN:	1664-2392, 1664-2392
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!